Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients: A clinical, prospective cohort study with one- year follow-up

Diseases of the Colon and Rectum

Volumn 52, Issue 3, 2009, Pages 446-451

  Stende, Mogens T ^a   Friokær, Jens B ^a   Larsen, Torben B ^b   SLren, Lundbye Christensen ^c   Olet, Thorlacius Ussing ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Cohort study; Colorectal cancer; D dimer; Prospective; Venous thrombo embolism

Indexed keywords

BIOLOGICAL MARKER; D DIMER; TINZAPARIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ARTICLE; CANCER PATIENT; COHORT ANALYSIS; COLORECTAL CANCER; COMPRESSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE MARKER; ECHOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK ASSESSMENT; THROMBOSIS PREVENTION; BLOOD; CLINICAL TRIAL; COLON RESECTION; COLORECTAL TUMOR; PREDICTION AND FORECASTING; PREOPERATIVE CARE; PREVALENCE; VEIN THROMBOSIS;

BIOLOGICAL MARKERS; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PREVALENCE; PROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 64549152511     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e318197e2b2     Document Type: Article

References (15)

1. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126: 338Y400.
2. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346: 975Y80.
3. Iversen LH, Thorlacius-Ussing O. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer. Thromb Haemost 2002;87: 402Y8.
4. Falanga A, Ofosu FA, Cortelazzo S, et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Br J Haematol 1993;85:745Y50.
5. Okholm M, Iversen LH, Thorlacius-Ussing O, Ejlersen E, Boesby S. Fibrin and fibrinogen degradation products in plasma of patients with colorectal adenocarcinoma. Dis Colon Rectum 1996;39:1102Y6.
6. Di Nisio M, Rutjes AW, Buller HR. Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis. J Thromb Haemost 2006;4:52Y7.
7. ten Wolde M, Kraaijenhagen RA, Prins MH, Buller HR. The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis. Arch Intern Med 2002; 162:1880Y4.
8. Stender MT, Nielsen TS, Frokjaer JB, Larsen TB, Lundbye- Christensen S, Thorlacius-Ussing O. High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer. Br J Surg 2007;94:1100Y3.
9. Satoh T, Oki A, Uno K, et al. High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer 2007;97:1053Y7.
10. Jespersen J, Bertina RM, Haverkate F. Laboratory techniques in thrombosis. A manual. 2nd revised edition of ECAT Assay Procedures. Dordrecht: Kluwer Academic Publishers, 1999.
11. Larsen TB, Stoffersen E, Christensen CS, Laursen B. Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays. J Intern Med 2002;252:36Y40.
12. Blackwell K, Hurwitz H, Lieberman G, et al. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer 2004; 101:77Y82.
13. Oya M, Akiyama Y, Yanagida T, Akao S, Ishikawa H. Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. Surg Today 1998;28:373Y8.
14. Dempfle CE, Zips S, Ergul H, Heene DL. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative Ddimer assays as basis for the development of D-dimer calibrators. FACT study group. Thromb Haemost 2001;85: 671Y8.
15. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874Y9.